Comprehensive histological evaluation of bone implants by Rentsch, Claudia et al.
 RepoRt
www.landesbioscience.com Biomatter e27993-1
Biomatter 4, e27993; February; © 2014 Landes Bioscience
RepoRt
Introduction
The biology of fracture healing is a complex biological process 
that follows a specific regenerative pattern and involves changes 
of the gene expression level. Bone rebuilds by either direct intra-
membranous (primary) or indirect (secondary) fracture healing. 
Indirect fracture healing consists of both intramembranous and 
endochondral bone formation and can be seen in large defects 
after operative fracture treatment, presenting weight bearing and 
thereby micro motion.1
Secondary bone repair occurs in 4 overlapping stages:
Stage I
The first stage, the initial inflammatory response, includes 
formation of the hematoma, inflammation and the recruitment 
of mesenchymal stem cells (MSC) as biological process.
Stage II
The second stage, the soft callus formation, encompasses 
chondrogenesis, endochondral and intramembraneous ossifica-
tion and angiogenesis. MSC are recruited in order to differentiate 
into chondrogenic and osteogenic line. Cells like chondroblasts, 
chondrocytes, chodroclasts as well as osteoblasts, osteocytes and 
osteoclasts are essential for the bone forming progression.
MSC can differentiate into chondroblasts and produce col-
lagen type II and proteoglycans to establish mechanical stability. 
Finally, cartilage undergoes hypertrophy and controlled miner-
alization. Chondroclasts remove the cartilage as soon as vessels 
invade so that woven bone formation can occur by MSC which 
underwent osteogenic differentiation. Osteoblasts synthesize 
a new collagenous organic matrix and regulate the mineraliza-
tion. When embedded in the newly produced matrix osteoblasts 
become osteocytes. Osteocytes develop a fine filopodia network 
to remain in cell-cell contact. Osteoclasts, derived from mono-
nuclear precursors, can bind to bone matrix peptides via integrin 
receptors and resorb the matrix.
The organic extracellular matrix (ECM) is composed of col-
lagens, glycoproteins, hyaluronic acid and proteoglycans. The 
ECM provides the structural scaffold for cells, growth factors 
and cytokines.
A three dimensional vascular network is formed in the bone 
defect by invading endothelial cells, smooth muscle cells, and 
pericytes.
Stage III
The third stage, the hard callus formation, is defined by osteo-
genesis, including bone cell recruitment and woven bone forma-
tion that takes place after chondrocyte apoptosis, chondroclast 
recruitment and cartilage resorption in the soft callus.
Stage IV
Stage four, bone remodeling, involves osteoblast, osteoclast 
and endothelial cell activity with resorption of the woven bone 
and formation of cortical and trabecular bone.1-3
Current clinical options in the treatment of large bone defects 
pose a continuous challenge in orthopedic surgery. Although 
currently available data provide complex information on bone 
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to investigate and assess bone regeneration in sheep in combination with new implant materials classical histologi-
cal staining methods as well as immunohistochemistry may provide additional information to standard radiographs or 
computer tomography. Available published data of bone defect regenerations in sheep often present none or sparely 
labeled histological images. Repeatedly, the exact location of the sample remains unclear, detail enlargements are miss-
ing and the labeling of different tissues or cells is absent. the aim of this article is to present an overview of sample 
preparation, staining methods and their benefits as well as a detailed histological description of bone regeneration in 
the sheep tibia. General histological staining methods like hematoxylin and eosin, Masson-Goldner trichrome, Movat’s 
pentachrome and alcian blue were used to define new bone formation within a sheep tibia critical size defect containing 
a polycaprolactone-co-lactide (pCL) scaffold implanted for 3 months (n = 4). Special attention was drawn to describe the 
bone healing patterns down to cell level. Additionally one histological quantification method and immunohistochemical 
staining methods are described.
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healing pathways, many open questions remain. To enhance 
fracture healing in critical bone defects different biomaterials, 
like hydroxyaptite, polymers, metals and composites4-6 have been 
proposed, but until now most of them are not incorporated into 
the clinical setting.7-9
The use of animal models has made it possible to investigate 
fracture healing in general and in addition with new implant 
materials. Histologically, the bone structure of younger sheep 
(age 1–4) is quite different (laminar cortical bone) compared 
with the secondary human bone structure. To investigate human 
like bone remodeling sheep with an age of 7–9 (which present 
secondary (osteonal) remodeling) have to be used.10
However, histological investigations about detailed healing 
stages in sheep large bone defects and the analysis of the par-
tial distribution of the cells with respect to the biomaterials are 
rare. Most presented histological figures of defect areas describe 
only the presence or absence of the implant material and bone.11-
15 Frequently, the location of the token picture within the defect 
area remains unclear, detail enlargements are missing and the 
labeling of different tissues or cells are simple or absent.16-21 More 
specific labeled histological images about cells and tissue can be 
found in the publications of Claes et al., Mastrogiacomo et al., 
Niemeyer et al., Gao et al., Marcacci et al., and Reichert et al. 
but some information is always missing.22-27 Informative detailed 
histological studies and images, with exhaustive evaluations, are 
presented for example by Lohfeld et al., Harms et al., and Liu 
et al.28-30
This investigation established general histological staining 
methods on ovine bone as a large animal model for bone healing 
studies. It has to be considered that this publication describes the 
investigation of a polymeric, porous implant and offers thereby a 
partial view of a complex histological issue. Different methodi-
cal problems can be encountered when processing other types of 
materials. Bones containing hard materials as metallic or ceramic 
implants have to undergo the cutting and grinding technique 
since they can’t be sectioned by a microtome. Metallic implants 
like screws could be removed before decalcification but usually 
not without small damages of the surrounding tissue, especially 
at the bone-biomaterial interface. Ceramic implants (e.g., calcium 
phosphate, hydroxyapatite, alumina, zirconia, and bioglasses) are 
not suitable to decalcification.
The aim of this study was to describe histological slides in 
detail to identify the bone healing patterns down to the cell level. 
A classification of cell and tissue type within the defect area, the 
state of bone healing, the performance of the implant material, 
the status of inflammation and vascularization was considered 
to evaluate the staining method as well as the healing process. 
The intention is to provide one concept for the description of the 
image location as well as detailed image labeling and to encour-
age scientists to plan and describe their explant sample prepa-
ration for bone histology at full-length. To achieve this goal a 
biomaterial (polycaprolactone-co-lactide [PCL]) was implanted 
in a sheep (age 6–9) tibia critical size defect (n = 4) for 3 mo.
This presentation will support the histological understand-
ing of sectional images relating to new bone formation on new 
implant materials.
Results and Discussion
Histological evaluation
New bone formation was detected with all histological stain-
ing methods at the proximal and distal ends of the 3 cm defect 
zone. The new bone was mainly localized in the external scaffold 
area. The new bone matrix enclosed the scaffold fibers without 
any connective tissue interface. No inflammatory reaction was 
visible around the implant material after 3 mo.
HE staining
HE staining allowed a general overview of the histological sec-
tion. Bone was presented as a compact structure in a dark red 
color. The connective tissue is more displayed as a structured net-
work of cells and collagen fibers in a lightly pink color (Fig. 2). 
Cartilage appears in a gray-pink mix but all tissues have to be 
Figure 1. Schematically drawing of sample preparation for histological investigations. (A) Sheep tibia defect stabilized by a marrow nail, beginning 
pCL scaffold implantation to fill the defect. (B) Callus formation within the defect zone after 3 mo of implantation, for histological/immunohistological 
evaluations sections through the whole defect zone were created. (C) Histological sections (3 µm) of each plane were used for all staining’s (He, Masson-
Goldner trichrome, modified Masson-Goldner trichrome, alcian blue, 1A4-Actin, osteopontin).
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morphological separated. The PCL scaffold material has been 
dissolved during the process of depolymerization. Therefore, 
the white spots in the histological sections present the original 
implant material. The amount of new calcified bone in the defect 
area as well as inside of the porous implant can be easily esti-
mated by HE staining.
Thorough analyses of histological sections allow far more 
detailed information about bone healing status and the func-
tion of the implant material. Different cell types and tissues can 
be determined by different histological staining methods like 
HE, Masson-Goldner trichrome, modified Masson-Goldner tri-
chrome, Movat’s pentachrome or alcian blue staining.
HE staining allowed different cell type localization only 
through morphological structure identification (Fig. 3). 
Osteocytes, osteoblast and chondrocytes could be distinguished 
in the hard tissue components whereas fibroblasts were located 
within the connective tissue. Areas of direct ossification (do) pre-
sented as structures of firm connective tissue showing positioned, 
tightly packed, large collagen fibers with less fibroblasts com-
pared with regular connective tissue (Fig. 3, [do] yellow arrow). 
Regions of cartilage formation could be detected in all histo-
logical section planes of the 3 cm defect area indicating endo-
chondral ossification (eo) (Fig. 3, [eo] yellow arrow). Signals of 
chronic inflammation (macrophages, foreign body giant cells or 
neutrophils could not be detected after 3 mo.
Masson-Goldner trichrome staining
Masson-Goldner trichrome staining is a commonly used 
method in bone histology and allows tissue identification by dif-
ferent coloring as well as by morphological identification.
In this investigation bone structures of the new build callus 
tissue were shown in a compact green color. The newly formed 
lamellar bone inside the scaffolds presented osteons including 
Haversian canals (see orange circle in Fig. 4A-C). The average 
diameter varied between 100 and 400 µm (Fig. 4C) and the 
number of lamellae ranged between 4 and 20 (Fig. 4D). Collagen 
fibrils are arranged in a helical order. The canals measured 
between 20–50 µm and contained up to 3 blood vessels which 
were surrounded by connective tissue (Fig. 4D). The detection of 
Haversian canals within the newly formed bone inside the scaf-
fold indicates a regular bone formation. The presence of vessels 
can be certainly detected when erythrocytes are seen that appear 
in a bright pink color (Fig. 4C).
According to their physiological localization, osteocytes 
and osteoblasts can be localized within the newly formed bone 
and at the margin of the trabeculae as lining cells respectively. 
Osteoclasts or chondroclasts can be visualized as polynucleated 
cells which appear in a red-brown color. The finding of osteo-
blasts and osteoclasts indicate a regulated process of bone forma-
tion and resorption. These findings indicate that after 3 mo of 
Figure 2. He staining overview. Bone is presented as a compact structure in a dark red color, connective tissue in light pink and the porous scaffold 
structure (pCL) in white. Areas of direct ossification present structures of firm connective tissue showing positioned collagen fibers. the drawing at the 
right top corner provides the orientation of the presented image (red frame). (original magnification 100x). B, Bone; Cg, cartilage; fct, firm connective 
tissue; ct, connective tissue.
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scaffold implantation the second and third stage of bone healing 
can be observed.
Radiographic measurements may provide information about 
the amount of new bone formation within the defect area but 
often there is no information about the presence and state of the 
implant material or the conditions of non calcified tissue. The 
quantification of an adequate amount of histological images is 
time consuming and complicated but one option of area quan-
tification will be presented here. First of all a modification of 
a standard staining method had to be done to allow a distinct 
separation of the different tissues to permit a defined threshold 
measurement for computer analysis.
Modified Masson-Goldner trichrome staining
The modified Masson-Goldner trichrome staining (Fig. 5A 
and B) allowed a clear separation of connective tissue (dark 
green) and bone matrix (yellow). Small islets of bony matrix at 
the inner parts of the scaffold straight around the scaffold fibers 
were detected indicating an osteogenic differentiation of the con-
nective tissue cells (Fig. 5B). The histological identification of 
single cells was more difficult because of the intense coloring.
The quantification of new bone formation within the scaf-
fold, the amount of connective tissue as well as the remaining 
PCL material was possible using the imaging software “cellD” 
(Fig. 5C and D).
On average, 44% new bone, 9% PCL material and 48% con-
nective tissue was seen in the defect area using histological color-
ing for quantitative measurements. The measurements correlated 
with additionally conducted micro-computer tomography show-
ing 51% new bone formation on average (data not shown).
Movat’s pentachrome staining
The Movat’s pentachrome staining presented one of the best 
coloring methods for detailed analysis of bone healing progres-
sions. Mature bone is shown in a compact structure in dark yel-
low compared with fibrous tissue in light yellow and cartilage 
tissue in green (Fig. 6A and B). New formed osteoids are colored 
in red (Fig. 6C, top left). The active stage of new bone accumula-
tion within the scaffold can be seen in Figure 6C (red staining). 
The maturing bone structures are clearly visible but they don’t 
show a well-organized osteonic structure yet.
The strong contrast between the yellow collagen fibers and 
the brown nuclei staining allowed a clear and comfortable iden-
tification of the existing cells and matrix. Osteoblasts, osteocytes 
and osteoids could be analyzed similar to the Masson-Goldner 
trichrome staining (Fig. 6A and B).
The formation of new collagen fibers is crucial for the esti-
mation of intramembranous ossification (direct new bone for-
mation). Collagen producing fibroblasts transport the collagen 
molecule into the extracellular space where they polymerize to 
larger fibrils. Casual fibrous tissue has small collagen and elastic 
fibers. Firm connective tissue presents with tightly packed colla-
gen clusters in different directions (see violet labeling in Fig. 6D). 
Increasing production of collagen matrix is directed by the differ-
entiating fibroblasts which take over an osteoblast-like function. 
During direct new bone formation the developing osteoblast 
transforms into an osteocyte within the collagen matrix.
Alcian blue staining
Endochondral ossification was visualized with alcian blue 
staining (Fig. 7), labeling glycosaminoglycans in a bright blue 
color. The chondrocytes were clearly detectable within the hya-
line cartilage structure and formed chondrones (Fig. 7). The 
dark blue coloring around the chondrones indicates a matrix rich 
in highly sulfated glycoseaminoglycans. In close proximity to the 
bone, a process of diverse remodeling was observed, consisting of 
loose and firm connective tissue and cartilage. Figure 7 represents 
a characteristic area of new bone formation in the PCL scaffold, 
with distinct areas marked showing cartilage and bone formation. 
The dark blue staining represents vesicular cartilage that pro-
duces calcified matrix and dying chondrocytes. Chondroclasts 
remove the matrix and ingrowing mesenchymal tissue incorpo-
rates vessels and osteoprogenitor cells which differentiate into 
Figure 3. He staining – detailed investigation. (A and B) Bone is presented as a compact structure in a dark red color, connective tissue in light pink and 
the porous scaffold structure (pCL) in white. (original magnification 200x). ob, osteoblast; oc, osteoclast; ot, osteocyte; fi, fibroblast; bv, blood vessel; rl, 
resorpition lacuna; Cg, cartilage; mL, chondrocyte; ccl, chondroclast; do, direct ossification; eo, endochondral ossification.
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osteoblast and form bone matrix. Figure 7 shows chondrocytes 
and their chondrones as well as matrix removing chondroclasts in 
the endochondral ossification area. Additionally, intramembra-
nous ossification is present, as well as fibroblasts, which produce 
a collagen matrix and firm connective tissue. Ingrowing progeni-
tor cells differentiate into osteoblasts and produce calcified bone 
matrix.
Table 1 provides an overview of the staining methods used 
in our study, the detected tissues and structures and finally the 
suggested application.
Immunochemical evaluation
Anti- α smooth muscle actin staining
Anti-α smooth muscle actin (1A4) staining was used to mark 
smooth muscle cells in vessel walls. Actins are highly conserved 
proteins that are involved in various types of cell motility and 
are ubiquitously expressed in all eukaryotic cells. The human 
antibody allowed a good cross reaction with ovine tissue and a 
specific detection of vessels.
A complete vascularization was observed in all sections of 
all animals. Vascularization occurred throughout the entire 3 
dimensional scaffold stack and included vessels ranging from 0.1 
to 1 mm in diameter (Fig. 8A).
Osteopontin
Osteopontin is a secreted, highly acidic, calcium binding, 
phosphorylated glycoprotein that is chemotactic for macro-
phages, smooth muscle cells, endothelial cells, and glial cells. 
Osteopontin binds over integrin, using an RGD signal, on cell 
surfaces. To interact with the ECM it can also bind on collagen 
I. The human antibody also permitted a specific cross reaction 
with ovine tissue.
Positive osteopontin staining (Fig. 8B, brown color) was evi-
dent at the firm connective tissue areas around the scaffold fibers 
as well as at the osteoblasts near the bone-connective tissue bor-
der. The high resolution picture in Figure 8 B shows osteopontin 
clearly associated within the collagen fibers.
Summary
All presented staining methods (HE, Masson-Goldner tri-
chrome, modified Masson-Goldner trichrome, Movat’s penta-
chrome and alcian blue staining) can be used to identify new 
bone formation within a porous polymeric implant. However, 
Figure 4. Masson-Goldner trichrome staining – detailed investigation. (A and B) Detailed description of new bone formation within the pCL scaffold. 
(C and D) Identical images presenting osteons in general (C, orange line) as well as measuring bars to describe the osteon size and the number of lamel-
lae (D); (original magnification: A, 100x; B and D, 200x). ob, osteoblast; oc, osteoclast; ot, osteocyte; on, osteon (orange); H, Haversian canal; fi, fibro-
blast; bv, blood vessel; rl, resorpition lacuna; e, erythrocyte; fct, firm connective tissue; black dashed line, lamellae; yellow bars, measuring of H or on.
e27993-6 Biomatter Volume 4 
they allow far more detailed information about the bone healing 
status and present cell types.
After 3 mo of PCL coll I/cs scaffold implantation in a critical 
size tibia defect all histological sections represented the second 
stage of the fracture healing according to Schindler et al.2 The 
scaffold was completely intermingled with vascularized, connec-
tive tissue (Figs. 4 and 8A), showing small bony islets around the 
PCL fibers at the inner part of the scaffold (Figs. 5 and 6), and 
intermediate states of bone formation (Figs. 2–6).
A general overview about implant material and new bone 
formation was given by HE and Masson-Goldener trichrome 
staining.
Modified Masson-Goldener trichrome staining allowed a dis-
tinct coloring between connective tissue, new bone formation 
and the dissolved implant material and could be used for quan-
titative measurements (Fig. 5). This coloring method has to be 
adjusted for other implant materials since other scaffolds might 
react differently during histological preparation.
In this investigation, the Movat’s pentachrome staining 
method provided the most distinct coloration between car-
tilage, mature bone, connective tissue new osteoids and cell 
nuclei. This staining method was optimal for the detection of 
intramembranous and / or endochondral ossification since cell 
(nuclei) and collagen fiber aggregation were considered as well as 
cartilage formation and/or new bone formation. Reichert et al. 
also used Movat’s pentachrome to describe the morphology of 
newly formed bone in polycaprolactone and tricalcium phosphate 
combined scaffolds in sheep defects. New osteoids, blood ves-
sels, osteoblast and osteoclasts were detected and labeled in these 
sections.27
Glucosaminoglycans and their producing chondroblasts and 
chondrocytes were clearly labeled by alcian blue staining (Fig. 7). 
Endochondal ossification (soft callus remodeling) represents a 
typical fracture healing stage according to the four stage model.2 
Multinucleated cells within the soft callus as well as at the new 
woven bone were detected. Based on the physical location of mul-
tinucleated cells, they are termed chondroclasts for cartilage and 
Figure  5. Modified Masson-Goldner trichrome staining: detailed investigation. (A) Modified Masson-Goldner trichrome, (B) detailed description, 
(C) original image for histological quantification using false coloring, (D) false coloring of image C using olympus software “cellD”. Connective tissue in 
green (45%), bone in yellow (35%) and pCL fiber in red (20%); (original magnification: A, C, and D, 100x; B, 400x). ob, osteoblast; ot, osteocyte; bv, blood 
vessel; nmb, new bone matrix; fct, firm connective tissue; ct, connective tissue.
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osteoclasts for bone.2 According to the callus remodeling system 
of Schindler et al. chondroclasts are the main effectors in carti-
lage resorption followed by endothelial cells for new vasculariza-
tion and bone formation.2
Additionally, a high osteogenic activity at the bone-connective 
tissue interface was evident by osteopontin staining, indicating 
intramembranous ossification. Osteoblasts and their progenitor 
cells are clearly stained by osteopontin (Fig. 8B, dark brown). 
Connective tissue invaded precursor cells (brown) showed a high 
osteogenic activity as well. Osteopontin is expressed by osteo-
cytes, osteoblast and their precursors as well as by osteoclasts and 
hypertrophic chondrocytes.31 It is assumed to be a multifunc-
tional protein that is involved in bone turnover and remodeling 
activities.
Conclusion
Standard histological staining methods on ex vivo samples can 
provide more information than there is bone or none. This study 
has demonstrated that different histological stains at explanted 
PCL bone implants approve individual qualities of information 
about tissue types, single cell types, the state of bone healing, the 
performance of the implant material, the status of inflammation 
and vascularization. Being familiar with the morphology of bone 
tissue and implant behavior a basic HE staining provides decent 
information. To achieve quantification options of single cells, 
special tissue areas or remaining implant materials more com-
plex staining methods (like Masson-Goldner trichrome, modi-
fied Masson-Goldner trichrome, Movat’s pentachrome) should 
be investigated. Regarding the actual results the authors recom-
mend Movat’s pentachrome staing for the analysis of the new 
growing tissue within the implant.
As a resume: Histology is a time consuming method but it 
provides excellent details in bone healing. Histology, radiographs 
and CT images can complement each other, giving different 
information and at different levels of investigation. Taken the 
time to describe sample preparation, the location of the presented 
Figure  6. Movat’s pentachrome staining:  detailed investigation. (A and B) Detailed description of new bone formation within the pCL scaffold. 
(C) Active stage of new bone accumulation, left top picture shows well organized new osteons. (D) enlargement of (B) (black frame) presenting detailed 
collagen structure, partly marked with violet lines; (original magnification: A and B, 100x). ob, osteoblast; oc, osteoclast; ot, osteocyte; H, Haversian 
canal; on, osteon (red circle); fi, fibroblast; bv, blood vessel; rl, resorpition lacuna; nmb, new bone matrix; no, new osteoids; Cg, cartilage; cf, collagen 
fibers.
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Figure 7. Alcian blue staining. Morphological identification of different cell types (orange circles) and ossification areas (endochondral or intramembra-
nous) within the scaffold. (original magnification 100x). ob, osteoblast; oc, osteoclast; ot, osteocyte; B, bone; fi, fibroblast; fct, firm connective tissue; 
Cg, cartilage; mL, chondrocyte; ccl, chondroclast; cd, chondrone.
Table 1. Final summary
Staining method Described color results Identifiable tissues and structures Suggested application
He
Nuclei: blue
eosinophilic structures: pink
Bone: dark pink
Connective tissue: light pink
Vessel containing erythrocytes: bright red
Nuclei: blue
General overview
Masson-Goldner trichrome
Nuclei: brown, black
Cytoplasm: red
erythrocytes: orange
Collagen: green
Bone: green, turquois
Connective tissue: light green
Vessel containing erythrocytes: pink
Nuclei: brown
General overview
Modified Masson-Goldner 
trichrome
Nuclei: brown, black
Cytoplasm: red
erythrocytes: orange
Collagen: yellow-green
Bone: beige/yellow
Connective tissue: dark green
Vessel containing erythrocytes: orange
Distinct separation of connective 
tissue and bone matrix  
for quantification
Movat’s pentachrome
Nuclei and elastic fibers: brown
Cartilage: green
Collagen: yellow
New osteoids: red
Bone: dark yellow
Connective tissue: light yellow
Cartilage: green
New osteoid: red
Nuclei: brown
optimal for detection  
of intramembranous and/or  
endochondral ossification
Alcian blue
Acid mucopolysaccharides and 
Glycosaminoglycans: blue
Nuclei: red-brown
Cartilage: dark blue
Connective tissue: gray/light blue
Bone: gray
Nuclei: red-brown
optimal for detection  
of endochondral ossification
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image and a detailed labeling of images, histology 
can improve information.
Material and Methods
PCL scaffold and coating
The textile polycaprolactone-co-lactide 
(Catgut GmbH, Markneukirchen, trade name: 
PCL) scaffolds with 19 mm external diameter 
were made on a computer aided embroidery 
machine. Scaffolds were coated with collagen 
type I and chondroitinsulfate (coll I/cs) like pre-
viously described.32 To create a 3 cm high, three 
dimensional implant, 30 single scaffold disks 
were piled up. The scaffold stack showed homo-
geneously distributed interconnected porosity of 
87% and a main pore size range of 0.1–0.8 mm.32
Surgical procedure
The study has been licensed by the regional 
board (24D-9168.11-1-2006-17), all animals were 
cared for according to the European guidelines for 
the care and use of laboratory animals (Directive 
24.11.1986, 86/609/CEE).
Female sheep (n = 4) with an average body 
weight of 65 kg and an age of 6–9 y were used for 
this study. Surgery was performed like previously 
described.33
A 3 cm long segmental mid-diaphyseal osteot-
omy was performed on the left tibia of each sheep. 
The tibia was stabilized by a prototype unreamed 
tibial nail (UTN, Clinical House GmbH). The 
3 cm resected bone segment, including its peri-
osteum, was removed. The defect was filled with 
surface coated coll I/cs scaffolds for 3 mo.
Histology/immunohistology
Explants were fixed in 4% neutral buffered 
formalin (SAV LP) for at least 7 d (Fig. S1). 
The samples were washed, decalcified for 4 
wk in EDTA (OSTEOSOFT, Merck KGaA, 
Darmstadt, Germany; to adjust pH to 7.4–7.6 use NaOH) using 
a automated microwave based tissue Processor RHS-1 (Diapath 
S.p.A,), dehydrated overnight in a Thermo Scientific STP 
420ES Tissue Processor (Microm International GmbH, Part of 
Thermo Fisher Scientific), and embedded in methyl methacry-
late (Technovit 9100 New, Heraeus Kulzer GmbH
The defect area was localized by measuring the distance 
between proximal and distal locking screw and the visible callus 
formation. The defect zone was cut in 7 equal section planes of 
0.5 cm, beginning and ending beyond the implant area (Fig. 1B). 
Sections of 3 µm of each section plane (Fig. 1C) were pre-
pared (rotation microtome RM2055, Leica Microsystems) and 
methyl-methacrylate was removed using twice xylene (VWR, 
International GmbH) for 20 min, twice 2-methoxyethylacetat 
for 20 min, and finally 96% ethanol. Samples were rehydrated in 
a graded series of ethanol in each case related to the ethanol con-
centration of the first staining solution. Samples were stained for 
light microscopy (Leica DMRBE Research Microscope, Camera 
Leica DC300, Leica Microsystems) as described below. Finally, 
sections were washed in 96% ethanol (2 min), xylene (5 min) and 
mounted in Canada-balsam-solution (Sigma-Aldrich Chemie 
GmbH) for investigation. Three histological sections of all sec-
tion planes were evaluated (Fig. 1B and C). Presented images 
were taken from the central part of the 3 cm defect area.
Haematoxylin and eosin (HE) staining
The sections were incubated for 15 min in hematoxylin 
(according to Mayer, VWR, International GmbH), followed by 
a differentiation step with water for 5 min and finally stained 
with eosin (VWR, International GmbH) for 1 min.
Masson-Goldner trichrome staining
Nuclei were stained for 15 min with hematoxylin according 
to Weigert (iron-hematoxylin-Kit, VWR, International GmbH) 
followed by azophloxin staining for 15 min. Samples were washed 
in acetic acid (1%) and placed in acid orange G solution. They 
Figure 8. Anti-α smooth muscle actin and osteopontin staining: detailed investigation. 
(A) Anti- α smooth muscle actin (1A4) staining (brown), nuclei are counter stained in blue, 
left: general overview, vessels are marked with a black arrow; right: smooth muscle cells 
in vessel walls. (B) osteopontin staining (brown), nuclei are counter stained in blue, black 
arrow marks positively stained cell-collagen-osteopontin bonds, left: general overview; 
right: osteopontin associated cell-collagen fiber construct, in vivo situation is schemati-
cally drawn in the upper right picture; (original magnification A and B, 100x).
Table 1. Final summary
Staining method Described color results Identifiable tissues and structures Suggested application
He
Nuclei: blue
eosinophilic structures: pink
Bone: dark pink
Connective tissue: light pink
Vessel containing erythrocytes: bright red
Nuclei: blue
General overview
Masson-Goldner trichrome
Nuclei: brown, black
Cytoplasm: red
erythrocytes: orange
Collagen: green
Bone: green, turquois
Connective tissue: light green
Vessel containing erythrocytes: pink
Nuclei: brown
General overview
Modified Masson-Goldner 
trichrome
Nuclei: brown, black
Cytoplasm: red
erythrocytes: orange
Collagen: yellow-green
Bone: beige/yellow
Connective tissue: dark green
Vessel containing erythrocytes: orange
Distinct separation of connective 
tissue and bone matrix  
for quantification
Movat’s pentachrome
Nuclei and elastic fibers: brown
Cartilage: green
Collagen: yellow
New osteoids: red
Bone: dark yellow
Connective tissue: light yellow
Cartilage: green
New osteoid: red
Nuclei: brown
optimal for detection  
of intramembranous and/or  
endochondral ossification
Alcian blue
Acid mucopolysaccharides and 
Glycosaminoglycans: blue
Nuclei: red-brown
Cartilage: dark blue
Connective tissue: gray/light blue
Bone: gray
Nuclei: red-brown
optimal for detection  
of endochondral ossification
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were then rinsed in 1% acetic acid, for 30 s and stained with light 
green for 5 min, then rinsed again in 1% acetic acid for 5 min 
(all solutions used from Masson-Goldner trichrome staining kit, 
Merck KGaA).
Modified Masson-Goldner trichrome staining
Nuclei were stained for 15 min with hematoxylin according 
to Weigert (Weigerts iron-hematoxylin-Kit, VWR, International 
GmbH). Modified trichrome staining according to Masson-
Goldner combines an azophloxin (15 min), orange G (5 min) and 
a 15 min aniline blue-tartrazine solution staining step (VWR, 
International GmbH). Tartrazine stains collagen structures in 
yellow and in combination with aniline blue which also stains 
collagen the final coloring results are various shades of green 
to yellow. Sections were washed with 3% acetic acid after each 
staining step.
Movat’s pentachrome staining
Sections were stained with 5% sodium thiosulfate for 5 min, 
washed for 5 min under cold running water, stained in 1% alcian 
blue for 20 min and washed again. The slides were placed in pre-
heated alkaline alcohol (60 °C) for 10 min, washed under run-
ning water than stained with hematoxylin according to Weigert 
(10 min), washed with water, then placed in Movat’s solution for 
60 min and washed again. Samples were stained with acid fuch-
sin for 1 min, differentiated in 1% acetic acid and incubated with 
5% phosphotungstic acid for 5 min (Movat pentachrome stain 
Kit, Diapath S.p.A). The slides were transferred directly into 1% 
acetic acid for 5 min and washed finally.
Alcian blue staining
The sections were washed with 3% acetic acid, stained with 
1% alcian blue (MORPHISTO® GmbH) for 60 min, and dif-
ferentiated with 3% acetic acid. Nuclei were counter stained with 
0.1% nuclear fast red solution (MORPHISTO® GmbH) for 5 
min and finally washed with water.
1A4-actin and osteopontin staining
For immunohistology, 3 µm sections were incubated with the 
primary antibody (mouse anti human smooth muscle Actin, clone 
1A4 (DAKO) or rabbit anti human osteopontin (Calbiochem, 
Merck Group) overnight at 4 °C, then incubated with biotin 
conjugated bridging antibody 1:150 in blocking solution (30 
min, 37 °C) and finally incubated in avidin-biotin conjugated 
peroxidase (Vectastain universal Elite Kit, Vector Laboratories) 
for 30 min. The immune reaction was visualized with Romulin 
(Biocare Medical) for 15 min at room temperature. Sections were 
counterstained with hematoxylin according to Mayer (VWR, 
International GmbH) (5 min). Samples incubated without pri-
mary antibody were used as control.
Histomorphometry
The imaging software “cellD” (Olympus life and material sci-
ence Europa GmbH, Hamburg, Germany) was used to quantify 
the amount of connective tissue, PCL scaffold and new bone 
within the defect zone. In total 252 gray scale pictures (36 pic-
tures per section plane) presenting the whole defect area were 
analyzed using defined thresholds for connective tissue, bone 
matrix or PCL (Fig. 5C). The 3 different phases were presented 
using a color coding function. Connective tissue is shown in 
green, bone matrix in yellow and PCL in red (Fig. 5D). Finally, 
the area of each threshold was measured in µm2 per picture.
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